Evidence map›Paper›PMID 28713270›Full record

ArticleFrontiers in pharmacology2017

Evaluation of Selected CYP51A1 Polymorphisms in View of Interactions with Substrate and Redox Partner.

Tadeja Režen, Iza Ogris, Marko Sever, Franci Merzel, Simona Golic Grdadolnik, Damjana Rozman

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Knockouts ofiScience · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Tadeja ReženFaculty of Medicine, Centre for Functional Genomics and Bio-Chips, Institute of Biochemistry, University of LjubljanaLjubljana, Slovenia.
Iza OgrisFaculty of Medicine, Centre for Functional Genomics and Bio-Chips, Institute of Biochemistry, University of LjubljanaLjubljana, Slovenia.
Marko SeverDepartment of Biomolecular Structure, National Institute of ChemistryLjubljana, Slovenia.
Franci MerzelDepartment of Biomolecular Structure, National Institute of ChemistryLjubljana, Slovenia.
Simona Golic GrdadolnikDepartment of Biomolecular Structure, National Institute of ChemistryLjubljana, Slovenia.
Damjana RozmanFaculty of Medicine, Centre for Functional Genomics and Bio-Chips, Institute of Biochemistry, University of LjubljanaLjubljana, Slovenia.
National Institute of Chemistry · SIUniversity of Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cholesterol is essential for development, growth, and maintenance of organisms. Mutations in cholesterol biosynthetic genes are embryonic lethal and few polymorphisms have been so far associated with pathologies in humans. Previous analyses show that lanosterol 14α-demethylase (CYP51A1) from the late part of cholesterol biosynthesis has only a few missense mutations with low minor allele frequencies and low association with pathologies in humans. The aim of this study is to evaluate the role of amino acid changes in the natural missense mutations of the hCYP51A1 protein. We searched SNP databases for existing polymorphisms of

Indexed as

CYP51A1molecular dynamics simulationspolymorphismPORSNP

Identifiers

PMID28713270
PMCPMC5492350
OpenAlexW2732661366

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.